Filing Details
- Accession Number:
- 0001209191-12-037740
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-07-10 14:11:29
- Reporting Period:
- 2012-07-06
- Filing Date:
- 2012-07-10
- Accepted Time:
- 2012-07-10 14:11:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1339455 | Somaxon Pharmaceuticals Inc. | SOMX | Pharmaceutical Preparations (2834) | 200161599 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1173408 | L.p. Iii Bioventures Mpm | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1173409 | L.p. Iii-Qp Bioventures Mpm | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1249063 | Mpm Bioventures Iii Parallel Fund, L.p. | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1249133 | Mpm Bioventures Iii Gmbh & Co. Beteiligungs Kg | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1249143 | L.p. Gp Iii Bioventures Mpm | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1249147 | Mpm Bioventures Iii Llc | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No | |
1346986 | Mpm Asset Management Investors 2005 Bviii Llc | C/O Mpm Asset Management 200 Clarendon Street, 54Th Floor Boston MA 02116 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-07-06 | 671,217 | $0.29 | 2,900,460 | No | 4 | S | Indirect | See Footnote |
Common Stock | Disposition | 2012-07-09 | 1,624,574 | $0.31 | 1,275,886 | No | 4 | S | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See Footnote |
No | 4 | S | Indirect | See Footnote |
Footnotes
- The shares were sold as follows: 559,506 by MPM BioVentures III-QP, L.P. ("BV III QP"), 37,622 by MPM BioVentures III, L.P. ("BV III"), 9,907 by MPM Asset Management Investors 2005 BVIII LLC ("AM 2005"), 16,901 by MPM BioVentures III Parallel Fund, L.P. ("BV Parallel") and 47,281 by MPM BioVentures III GmbH & Co. Beteiligungs KG ("BV KG"). MPM BioVentures III GP, L.P. ("MPM III GP") and MPM BioVentures III LLC ("MPM III LLC") are the direct and indirect general partners of BV III QP, BV III, BV Parallel and BV KG. Luke Evnin, Ansbert Gadicke, Nicholas Galakatos, Dennis Henner, Nicholas Simon III, Michael Steinmetz and Kurt Wheeler are the Series A members of MPM III LLC and the managers of AM 2005.
- The shares are held as follows: 2,417,716 by BV III QP, 162,570 by BV III, 42,835 by AM 2005, 73,032 by BV Parallel and 204,307 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.
- The shares were sold as follows: 1,354,196 by BV III QP, 91,057 by BV III, 23,979 by AM 2005, 40,907 by BV Parallel and 114,435 by BV KG.
- The shares are held as follows: 1,063,520 by BV III QP, 71,513 by BV III, 18,856 by AM 2005, 32,125 by BV Parallel and 89,872 by BV KG. Each Reporting Person disclaims beneficial ownership of the securities except to the extent of his or its respective pecuniary interest therein.